Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species (ROS) generation in inflammatory signaling refers to the production of highly reactive oxygen-containing molecules, such as superoxide and hydrogen peroxide, which serve as critical mediators in the immune response [1]. These species are primarily produced by enzymes like NADPH oxidases (NOX) and the mitochondrial electron transport chain in response to inflammatory stimuli like cytokines or pathogens [2]. While physiological levels of ROS are essential for cell signaling and host defense, their excessive or chronic production leads to oxidative stress, which triggers downstream pathways such as NF-kappaB and the NLRP3 inflammasome [3]. This sustained activation promotes the expression of pro-inflammatory genes, contributing to the pathogenesis of chronic diseases including rheumatoid arthritis, atherosclerosis, and neurodegeneration [4]. Therapeutic intervention typically involves the use of antioxidants to scavenge ROS or specific inhibitors to block ROS-producing enzymes like NOX2 [5]. However, targeting this process is challenging because ROS also play vital roles in normal cellular functions, such as wound healing and pathogen killing [6]. Consequently, non-selective inhibition can lead to impaired immunity or disrupted homeostatic signaling, a phenomenon often referred to as the antioxidant paradox [6].
Inhibition of ROS-producing enzymes (e.g., NADPH oxidase), direct scavenging of reactive species, or induction of endogenous antioxidant defense systems.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species generation in inflammatory signaling (ROS).